Cavitation Technologies Competitors

Cavitation Technologies (OTCMKTS:CVAT) and Nutrien (NYSE:NTR) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends.

Analyst Recommendations

This is a summary of current recommendations and price targets for Cavitation Technologies and Nutrien, as reported by MarketBeat.com.

Nutrien has a consensus price target of $46.4706, indicating a potential downside of 5.95%. Given Nutrien's higher probable upside, analysts clearly believe Nutrien is more favorable than Cavitation Technologies.

Earnings & Valuation

This table compares Cavitation Technologies and Nutrien's gross revenue, earnings per share and valuation.

Nutrien has higher revenue and earnings than Cavitation Technologies.

Profitability

This table compares Cavitation Technologies and Nutrien's net margins, return on equity and return on assets.

Insider and Institutional Ownership

63.2% of Nutrien shares are owned by institutional investors. 3.1% of Nutrien shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Nutrien beats Cavitation Technologies on 9 of the 9 factors compared between the two stocks.

Cavitation Technologies (OTCMKTS:CVAT) and The Scotts Miracle-Gro (NYSE:SMG) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends.

Analyst Recommendations

This is a summary of current recommendations and price targets for Cavitation Technologies and The Scotts Miracle-Gro, as reported by MarketBeat.com.

The Scotts Miracle-Gro has a consensus price target of $161.75, indicating a potential downside of 5.84%. Given The Scotts Miracle-Gro's higher probable upside, analysts clearly believe The Scotts Miracle-Gro is more favorable than Cavitation Technologies.

Earnings & Valuation

This table compares Cavitation Technologies and The Scotts Miracle-Gro's gross revenue, earnings per share and valuation.

The Scotts Miracle-Gro has higher revenue and earnings than Cavitation Technologies.

Profitability

This table compares Cavitation Technologies and The Scotts Miracle-Gro's net margins, return on equity and return on assets.

Insider and Institutional Ownership

64.9% of The Scotts Miracle-Gro shares are owned by institutional investors. 28.2% of The Scotts Miracle-Gro shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

The Scotts Miracle-Gro beats Cavitation Technologies on 8 of the 8 factors compared between the two stocks.

Cavitation Technologies (OTCMKTS:CVAT) and The Mosaic (NYSE:MOS) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends.

Insider and Institutional Ownership

71.6% of The Mosaic shares are owned by institutional investors. 0.5% of The Mosaic shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Cavitation Technologies and The Mosaic's gross revenue, earnings per share and valuation.

Cavitation Technologies has higher earnings, but lower revenue than The Mosaic.

Analyst Recommendations

This is a summary of current recommendations and price targets for Cavitation Technologies and The Mosaic, as reported by MarketBeat.com.

The Mosaic has a consensus price target of $18.2368, indicating a potential downside of 19.63%. Given The Mosaic's higher probable upside, analysts clearly believe The Mosaic is more favorable than Cavitation Technologies.

Profitability

This table compares Cavitation Technologies and The Mosaic's net margins, return on equity and return on assets.

Summary

The Mosaic beats Cavitation Technologies on 5 of the 6 factors compared between the two stocks.

CF Industries (NYSE:CF) and Cavitation Technologies (OTCMKTS:CVAT) are both basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

Insider and Institutional Ownership

88.9% of CF Industries shares are owned by institutional investors. 2.0% of CF Industries shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares CF Industries and Cavitation Technologies' revenue, earnings per share (EPS) and valuation.

CF Industries has higher revenue and earnings than Cavitation Technologies.

Analyst Ratings

This is a breakdown of recent ratings and target prices for CF Industries and Cavitation Technologies, as provided by MarketBeat.

CF Industries presently has a consensus target price of $38.0769, indicating a potential downside of 1.89%. Given CF Industries' higher possible upside, research analysts plainly believe CF Industries is more favorable than Cavitation Technologies.

Profitability

This table compares CF Industries and Cavitation Technologies' net margins, return on equity and return on assets.

Summary

CF Industries beats Cavitation Technologies on 8 of the 8 factors compared between the two stocks.

ICL Group (NYSE:ICL) and Cavitation Technologies (OTCMKTS:CVAT) are both basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

Insider and Institutional Ownership

4.3% of ICL Group shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares ICL Group and Cavitation Technologies' revenue, earnings per share (EPS) and valuation.

ICL Group has higher revenue and earnings than Cavitation Technologies.

Analyst Ratings

This is a breakdown of recent ratings and target prices for ICL Group and Cavitation Technologies, as provided by MarketBeat.

ICL Group presently has a consensus target price of $5.50, indicating a potential upside of 15.30%. Given ICL Group's higher possible upside, research analysts plainly believe ICL Group is more favorable than Cavitation Technologies.

Profitability

This table compares ICL Group and Cavitation Technologies' net margins, return on equity and return on assets.

Summary

ICL Group beats Cavitation Technologies on 6 of the 6 factors compared between the two stocks.

American Vanguard (NYSE:AVD) and Cavitation Technologies (OTCMKTS:CVAT) are both basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

Insider and Institutional Ownership

63.6% of American Vanguard shares are owned by institutional investors. 5.3% of American Vanguard shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares American Vanguard and Cavitation Technologies' revenue, earnings per share (EPS) and valuation.

American Vanguard has higher revenue and earnings than Cavitation Technologies.

Analyst Ratings

This is a breakdown of recent ratings and target prices for American Vanguard and Cavitation Technologies, as provided by MarketBeat.

Profitability

This table compares American Vanguard and Cavitation Technologies' net margins, return on equity and return on assets.

Summary

American Vanguard beats Cavitation Technologies on 6 of the 6 factors compared between the two stocks.